News
AXGN
50.40
+8.53%
3.96
Weekly Report: what happened at AXGN last week (0810-0814)?
Weekly Report · 5d ago
AxoGen Earnings Call Highlights Strong Growth, Margin Strain
TipRanks · 08/12 00:21
Weekly Report: what happened at AXGN last week (0803-0807)?
Weekly Report · 08/10 09:19
Analysts’ Top Healthcare Picks: Dexcom (DXCM), AxoGen (AXGN)
TipRanks · 08/04 14:20
Weekly Report: what happened at AXGN last week (0727-0731)?
Weekly Report · 08/03 09:19
Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel
Seeking Alpha · 08/03 06:37
Axogen Is Maintained at Buy by Canaccord Genuity
Dow Jones · 07/30 15:46
Axogen Price Target Raised to $55.00/Share From $50.00 by Canaccord Genuity
Dow Jones · 07/30 15:46
Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $55
Benzinga · 07/30 15:38
Axogen Is Maintained at Market Outperform by Citizens
Dow Jones · 07/30 14:11
Axogen Price Target Raised to $55.00/Share From $50.00 by Citizens
Dow Jones · 07/30 14:11
Citizens Maintains Market Outperform on Axogen, Raises Price Target to $55
Benzinga · 07/30 14:02
AxoGen price target raised to $55 from $50 at Jefferies
TipRanks · 07/30 13:32
Axogen Price Target Raised to $53.00/Share From $50.00 by HC Wainwright & Co.
Dow Jones · 07/30 11:22
Axogen Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 07/30 11:22
AxoGen price target raised to $53 from $50 at H.C. Wainwright
TipRanks · 07/30 10:05
AxoGen price target raised to $55 from $50 at Citizens
TipRanks · 07/30 09:45
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Incyte (INCY)
TipRanks · 07/29 14:00
AxoGen boosts outlook after strong second-quarter growth
TipRanks · 07/29 11:28
More
Webull provides a variety of real-time AXGN stock news. You can receive the latest news about Axogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About AXGN
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.